Prolongation of survival in Hodgkin's disease.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000477:Alkylating Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006689:Hodgkin Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012737:Sex Factors; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use*
D000477:Alkylating Agents; D001565:Benzoates; D014747:Vinblastine; D011241:Prednisone